C5 and Alzheimer disease: We propose more investigations into the connection between C5a, C1q, and CR1 with NETs in AD, as well as genetic associations studies to investigate variants in DNase genes (DNASE1, DNASE2, and DNASE1L3) that can result in a down-regulation of DNase expression in AD.